Challenge model for Helicobacter pylori infection in human volunteers

Gut. 2004 Sep;53(9):1235-43. doi: 10.1136/gut.2003.037499.

Abstract

Background: A reliable challenge model is needed to evaluate Helicobacter pylori vaccine candidates.

Methods: A cag pathogenicity island negative, OipA positive, multiple antibiotic susceptible strain of H pylori obtained from an individual with mild gastritis (Baylor strain 100) was used to challenge volunteers. Volunteers received 40 mg of famotidine at bedtime and 10(4)-10(10) cfu of H pylori in beef broth the next morning. Infection was confirmed by (13)C urea breath test ((13)C-UBT), culture, and histology. Eradication therapy was given four or 12 weeks post challenge and eradication was confirmed by at least two separate UBTs, as well as culture and histology.

Results: Twenty subjects (nine women and 11 men; aged 23-33 years) received a H pylori challenge. Eighteen (90%) became infected. Mild to moderate dyspeptic symptoms occurred, peaked between days 9 and 12, and resolved. Vomitus from one subject contained >10(3) viable/ml H pylori. By two weeks post challenge gastric histology showed typical chronic H pylori gastritis with intense acute and chronic inflammation. The density of H pylori (as assessed by cfu/biopsy) was similarly independent of the challenge dose. A minimal infectious dose was not found. Gastric mucosal interleukin 8 levels increased more than 20-fold by two weeks after the challenge.

Conclusion: Challenge reliably resulted in H pylori infection. Infection was associated with typical H pylori gastritis with intense polymorphonuclear cell infiltration and interleukin 8 induction in gastric mucosa, despite absence of the cag pathogenicity island. Experimental H pylori infection is one of the viable approaches to evaluate vaccine candidates.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Vaccines
  • Dyspepsia / microbiology
  • Female
  • Follow-Up Studies
  • Gastric Acidity Determination
  • Gastritis / immunology
  • Gastritis / microbiology*
  • Gastritis / pathology
  • Helicobacter Infections / drug therapy
  • Helicobacter Infections / immunology
  • Helicobacter Infections / microbiology
  • Helicobacter Infections / pathology*
  • Helicobacter pylori / drug effects
  • Helicobacter pylori / pathogenicity*
  • Humans
  • Hydrogen-Ion Concentration
  • Interleukins / biosynthesis
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Nontherapeutic Human Experimentation*
  • Virulence

Substances

  • Anti-Bacterial Agents
  • Bacterial Vaccines
  • Interleukins